Roche Unit To Pay Up To $1.7B For US Cancer Drugmaker
A unit of Swiss pharmaceutical giant Roche Holding AG has agreed to acquire San Diego-based venture-backed biotechnology company Seragon Pharmaceuticals Inc. in a deal worth up to $1.7 billion, giving Roche...To view the full article, register now.
Already a subscriber? Click here to view full article